Abstract:Ferroptosis is a newly described form of regulated cell death, distinct from apoptosis, necroptosis and other forms of cell death. Ferroptosis is induced by disruption of glutathione synthesis or inhibition of glutathione peroxidase 4, exacerbated by iron, and prevented by radical scavengers such as ferrostatin-1, liproxstatin-1, and endogenous vitamin E. Ferroptosis terminates with mitochondrial dysfunction and toxic lipid peroxidation. Although conclusive identification of ferroptosis in vivo is challenging, several salient and very well established features of neurodegenerative diseases are consistent with ferroptosis, including lipid peroxidation, mitochondrial disruption and iron dysregulation. Accordingly, interest in the role of ferroptosis in neurodegeneration is escalating and specific evidence is rapidly emerging. One aspect that has thus far received little attention is the antioxidant transcription factor nuclear factor erythroid 2-related factor 2 (Nrf2). This transcription factor regulates hundreds of genes, of which many are either directly or indirectly involved in modulating ferroptosis, including metabolism of glutathione, iron and lipids, and mitochondrial function. This potentially positions Nrf2 as a key deterministic component modulating the onset and outcomes of ferroptotic stress. The minimal direct evidence currently available is consistent with this and indicates that Nrf2 may be critical for protection against ferroptosis. In contrast, abundant evidence demonstrates that enhancing Nrf2 signaling is potently neuroprotective in models of neurodegeneration, although the exact mechanism by which this is achieved is unclear. Further studies are required to determine to extent to which the neuroprotective effects of Nrf2 activation involve the prevention of ferroptosis.

Ferroptosis regulation through Nrf2 and implications for neurodegenerative diseases

Insight into the Role of Ferroptosis in Non-neoplastic Neurological Diseases

Mechanisms of Ferroptosis and Emerging Links to the Pathology of Neurodegenerative Diseases

Nrf2 and Ferroptosis: A New Research Direction for Neurodegenerative Diseases

The role of ferroptosis in neurodegenerative diseases

Nrf2 and Ferroptosis: Exploring Translational Avenues for Therapeutic Approaches to Neurological Diseases

The role of non-coding RNAs in ferroptosis regulation

Research progress on ferroptosis in the pathogenesis and treatment of neurodegenerative diseases

Research on Ferroptosis as a Therapeutic Target for the Treatment of Neurodegenerative Diseases

Insight into the potential role of ferroptosis in neurodegenerative diseases

Targeting Molecular Mediators of Ferroptosis and Oxidative Stress for Neurological Disorders

Ferroptosis and Its Potential Role in the Nervous System Diseases

Ferroptosis: A potential therapeutic target for neurodegenerative diseases

Targeting Nrf2 to Suppress Ferroptosis and Mitochondrial Dysfunction in Neurodegeneration

Toward Improved Human Health: Nrf2 Plays a Critical Role in Regulating Ferroptosis

Understanding the Mechanism of Ferroptosis in Neurodegenerative Diseases

Ferroptosis Mediated by Lipid Reactive Oxygen Species: A Possible Causal Link of Neuroinflammation to Neurological Disorders

A critical appraisal of ferroptosis in Alzheimer's and Parkinson's disease: new insights into emerging mechanisms and therapeutic targets

Ferroptosis: A new strategy for targeting Alzheimer's disease

NRF2, a Superstar of Ferroptosis

New insights into crosstalk between Nrf2 pathway and ferroptosis in lung disease